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        Introduction 
  Growth factor signaling mediates cell proliferation and differ-
entiation and is a tightly regulated process. Both activation and 
inactivation of signaling cascades are controlled by multiple 
mechanisms to ensure a correct cellular response level to a 
given stimulus. Endocytosis and endosomal sorting of growth 
factor receptors is a major mechanism for such inactivation by 
internalizing and sorting activated receptors into intraluminal 
vesicles of multivesicular bodies. This renders the receptors in-
accessible for peripheral signaling components and destines 
them for degradation in lysosomes (  Felder et al., 1990  ). 
  Receptors due to follow the pathway toward lysosomal 
degradation are distinguished from those destined for other trans-
port routes by the covalent addition of the small protein ubiquitin 
to the cytosolic region of the receptor, extensively studied in the 
case of the EGF receptor (EGFR). This sorting event occurs at 
early endosomes, where a protein complex containing the hepato-
cyte growth factor  –  regulated tyrosine kinase substrate (Hrs) 
recruits ubiquitinated receptors to clathrin-coated microdo-
mains (  Raiborg et al., 2002  ). In concert with the evolutionarily 
conserved endosomal sorting complex required for transport 
(ESCRT) machinery, which consists of the ESCRT-I, -II and -III 
complexes, Hrs mediates the formation of intraluminal endo-
somal vesicles and the accumulation of receptors in these vesicles 
(  Katzmann et al., 2001  ;   Babst et al., 2002a  ,  b  ;   Bache et al., 2003  ). 
The initial recruitment of a ubiquitinated receptor to the sorting 
machinery is thought to be mediated by direct interactions 
between the ubiquitin moiety and a ubiquitin-interacting motif 
(UIM) in Hrs (  Bilodeau et al., 2002  ;   Raiborg et al., 2002  ;   Hirano 
et al., 2006  ). Hrs is localized to early endosomes via an inter-
action with phosphatidylinositol-3-phosphate (  Raiborg et al., 
2001b  ). In addition to recruiting ubiquitinated cargo to early 
endosomes, Hrs is required for endosomal localization of several 
components of the sorting machinery, including signal-transducing 
adaptor molecule (STAM), ESCRT-I, and clathrin. Depleting 
cells of Hrs results in impaired degradation of activated EGFR, 
which illustrates the essential role of Hrs in the process of endo-
somal protein sorting (  Bache et al., 2003  ). 
  D
own-regulation of activated and ubiquitinated 
growth factor (GF) receptors by endocytosis and 
subsequent lysosomal degradation ensures attenua-
tion of GF signaling. The ubiquitin-binding adaptor pro-
tein Eps15 (epidermal growth factor receptor [EGFR] 
pathway substrate 15) functions in endocytosis of such re-
ceptors. Here, we identify an Eps15 isoform, Eps15b, and 
demonstrate its expression in human cells and conserva-
tion across vertebrate species. Although both Eps15 and 
Eps15b interact with the endosomal sorting protein Hrs 
(hepatocyte growth factor  –  regulated tyrosine kinase sub-
strate) in vitro, we ﬁ  nd that Hrs speciﬁ  cally binds Eps15b 
in vivo (whereas adaptor protein 2 preferentially interacts 
with Eps15). Although Eps15 mainly localizes to clathrin-
coated pits at the plasma membrane, Eps15b localizes to 
Hrs-positive microdomains on endosomes. Eps15b over-
expression, similarly to Hrs overexpression, inhibits ligand-
mediated degradation of EGFR, whereas Eps15 is without 
effect. Similarly, depletion of Eps15b but not Eps15 delays 
degradation and promotes recycling of EGFR. These re-
sults indicate that Eps15b is an endosomally localized 
isoform of Eps15 that is present in the Hrs complex via di-
rect Hrs interaction and important for the sorting function 
of this complex.
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  Results 
  An Eps15-related protein is found in 
bilayered clathrin coats on endosomes 
  Previous studies have shown that Hrs resides in a characteristic 
 “ bilayered ”  clathrin coat on early endosomes, where it is involved 
in retention and lysosomal sorting of ubiquitinated membrane 
proteins (  Raiborg et al., 2002  ;   Sachse et al., 2002  ). Clathrin ap-
pears to retain Hrs molecules in restricted microdomains, thereby 
increasing their local concentration beyond a critical value required 
for cargo sorting through low-affi  nity interactions (  Raiborg 
et al., 2006 ). Confocal microscopy has shown that an anti-Eps15 
immunoreactive protein colocalizes with Hrs on endosomes 
(  Bache et al., 2003  ) but the resolution of the light microscope is 
insuffi  cient to establish whether Eps15 is present in the bi-
layered clathrin coat. To address this issue, we studied HEp-2 and 
HeLa cells by immunoelectron microscopy using an antibody 
against the C-terminal part of Eps15 followed by protein A con-
jugated to colloidal gold. The endosomal labeling with anti-
Eps15 was low and we rarely detected more than one immunogold 
particle per endosome. However, the labeling was highly spe-
cifi  c, and we consistently detected anti-Eps15 labeling within 
the bilayered coat of endosomes (  Fig. 1 A  ). Double labeling 
with anti-Eps15 and anti-Hrs showed that the bilayered Eps15-
positive coat contained Hrs as well (  Fig. 1 B  ). As reported pre-
viously (  Raiborg et al., 2002  ,   Sachse et al., 2002  ), this coat was 
morphologically distinct from clathrin-coated pits at the plasma 
membrane, in which we could also detect Eps15 labeling (  Fig. 
1 A  , inset). These results indicate that an Eps15-related protein 
is found in the bilayered clathrin coats on endosomes. 
  Eps15b is an isoform of Eps15 
 The  fi  nding that Eps15 proteins localize to two distinct mem-
branes begged the question of whether the form of Eps15 resid-
ing in bilayered clathrin coats on endosomes might be distinct 
from the canonical clathrin-coated pit-associated form. Indeed, 
in their initial characterization of Eps15,   Fazioli et al. (1993)   
identifi  ed several protein species recognized by Eps15 anti-
bodies and introduced the idea of possible isoforms of Eps15. 
  In addition to Hrs and STAM, the endocytic adaptor pro-
tein Eps15 has been reported to participate in the Hrs complex 
via a direct interaction with Hrs (  Bean et al., 2000  ;   Bache 
et al., 2003  ). The role of Eps15 in the more upstream process 
of endocytosis has been extensively studied, establishing Eps15 
as a part of the complex protein interaction network present at 
clathrin-coated pits (  Salcini et al., 1999  ;   Conner and Schmid, 
2003  ;   Sigismund et al., 2005  ). Eps15 is constitutively associated 
with the clathrin-coated pit adaptor protein 2 (AP2) complex 
and is localized to the cytosol and the rims of clathrin-coated 
pits (  Benmerah et al., 1995  ;   Tebar et al., 1996  ). The Eps15 
protein consists of several functional domains (  Fazioli et al., 
1993  ). The three N-terminal Eps15 homology (EH) domains 
are protein  –  protein interaction modules responsible for the 
majority of the interactions Eps15 form with other proteins 
(  Wong et al., 1995  ;   Salcini et al., 1997  ;   Polo et al., 2003  ). 
These domains further mediate the ability of Eps15 to stimu-
late clathrin assembly at emerging clathrin coated pits through 
interacting with the adaptor protein AP180 and are further-
more required for the recruitment of Eps15 to clathrin-coated 
pits (  Benmerah et al., 1999  ;   Morgan et al., 2003  ). The inter-
mediate coiled-coil domain serves as the interacting surface 
for the constitutive oligomerization of Eps15 and can addi-
tionally interact with Hrs (  Tebar et al., 1997  ;   Bean et al., 
2000  ). Toward the C-terminal end of the protein, a series of 
DPF repeats constitute the binding domain needed for the as-
sociation with AP2, and this domain is also capable of inter-
acting with Hrs (  Benmerah et al., 1996  ;   Bean et al., 2000  ). 
The C terminus of Eps15 contains two UIMs, the last of which 
is indispensable for the ability of Eps15 to bind ubiquitin, 
whereas both UIMs are necessary for monoubiquitination of 
Eps15 itself (  Polo et al., 2002  ). Although the bulk of Eps15 
resides in the cytosol or at clathrin-coated pits, a small pool of 
Eps15 has been reported to localize to early endosomes. The 
functional signifi  cance of the endosomally localized Eps15 is 
unknown. Here, we identify a novel isoform of Eps15, Eps15b, 
and show evidence that this protein localizes to endosomes 
and participates with Hrs in endosomal sorting of endocytosed 
growth factor receptors. 
  Figure 1.       An Eps15-related protein is present 
in bilayered coats on endosomes.   (A) HEp-2 
cells incubated with EGF on ice and chased 
for 15 min at 37  °  C were prepared for immuno-
electron microscopy and labeled using an 
antibody recognizing the C terminus of Eps15. 
(B) HeLa cells incubated with EGF on ice and 
chased for 15 min at 37  °  C were prepared for 
immunoelectron microscopy and labeled for 
Eps15 (15 nm gold) followed by labeling 
for Hrs (10 nm gold, arrows). The labeling for 
Eps15 localized to bilayered coats on endo-
some-like compartments as well as to the rim 
of coated pits at the plasma membrane (inset 
in A). The two micrographs shown in A are 
from the same cell. Coats are indicated by 
arrowheads. Bars, 100 nm.     1207 EPS15B AND ENDOSOMAL SORTING   •   ROXRUD ET AL.
Eps15 resulting from translation of exon 1  –  12. Consequently, 
the Eps15b form lacks the three N-terminal EH domains 
required for the recruitment of Eps15 to clathrin-coated pits 
(  Benmerah et al., 1999  ). The N-terminal Eps15b-specifi  c se-
quence served to identify EST clones corresponding to the 
Eps15b isoform isolated from different human tissues, such as 
brain (GenBank/EMBL/DDBJ accession no.   DA801048  ) and 
embryonic stem cells (GenBank/EMBL/DDBJ accession no. 
  CN346061  ). The EST clones identifi  ed differ slightly with re-
spect to the 5     end, and further analyses are required to verify 
the exact transcriptional start site. Quantitative real-time PCR 
using Eps15b-specifi  c primers revealed that Eps15b is ex-
pressed in HeLa cells (see the following paragraph), and to-
gether these results indicate that the Eps15b isoform is expressed 
in a variety of human cell types. The Eps15b unique sequence 
further enabled the identifi  cation of related cDNA clones repre-
senting putative homologues in other animal species, indicating 
that the isoform is conserved across species. The predicted 
N-terminal amino acid sequences of these putative Eps15b 
homologues displayed 84% conservation between humans and 
birds in the Eps15b-specifi  c region, indicating a strong conser-
vation pressure (  Fig. 2 C  ). 
  To compare Eps15b with the putative Eps15 isoforms 
previously observed, we translated the protein in vitro. West-
ern blot analysis revealed that Eps15b migrates at    120  kD 
(  Fig. 3 A  ). In line with this observation,   Fazioli et al. (1993)   
Through searches in public databases, we identifi  ed a putative 
isoform of Eps15 on the basis of a full-length cDNA sequence 
(GenBank/EMBL/DDBJ accession no.   BX647676  ; isolated 
from a human colon endothelial primary cell culture) and named 
it Eps15b (  Fig. 2 A  ). The   EPS15B   sequence comprises exons 
13 – 25  of  the   EPS15   gene and upstream 245 additional nucleo-
tides. These 245 nucleotides align with the 3     end of intron 12 
according to the genomic sequence of   EPS15   and we conse-
quently defi  ned this region of intron 12 as an alternative tran-
scriptional initiation exon. These 245 nucleotides form the 
5     end of the   EPS15B   isoform and suggest that an alternative 
promoter and transcriptional start site (TSS) exists in intron 12. 
The DataBase of Human Transcription Start Sites (  Suzuki 
et al., 2004  ), containing large-scale information on TSSs based 
on experimentally determined TSSs of human genes, identifi  es 
several TSSs in the   ±  30 nucleotide vicinity of the   EPS15B   start 
site, which suggests that this region is an active site of transcrip-
tional initiation. 
 The   EPS15B   sequence contains an ATG translational start 
site with an open reading frame predicted to produce a protein 
of 582 amino acids (  Fig. 2 B  ). Out of these 582 residues, the 
fi  rst 32 are unique for Eps15b and, as the ATG in the alternative 
initiation exon lies in frame with the Eps15 sequence starting at 
exon 13, it is followed by the 550 most C-terminal residues of 
Eps15. The resulting Eps15b protein is truncated in the N ter-
minus relative to Eps15 and lacks the 346 fi  rst amino acids of 
  Figure 2.       Eps15b is an isoform of Eps15.   (A) The   EPS15   gene contains 25 annotated exons. Eps15 is produced from exons 1  –  25, whereas the Eps15b 
isoform originates from a transcriptional initiation in intron 12 continuing through exons 13  –  25. (B) The Eps15 protein contains several functional protein 
domains: three EH domains, a coiled-coil region, a DPF repeat domain, and two consecutive UIMs. The Eps15b isoform lacks the three EH domains and 
contains a short unique N-terminal region. The remaining part of the protein is identical to Eps15 and contains major parts of the coiled coil region in 
addition to the DPF repeat domain and the UIM motives. (C) Multiple sequence alignment of the predicted protein sequences for the putative Eps15b 
homologues in   Homo sapiens   (BX647676),   Macaca fascicularis   (AB172746),   Mus musculus   (BAC38796),   Gallus gallus   (CR407454), and   Bos taurus   
(DV911715) compared with Eps15 from   H. sapiens  . The sequences in blue and red represent the N-terminal 32 Eps15b-speciﬁ  c sequences (conserved 
residues are shown in blue and unconserved residues in red), whereas the sequence in black indicates where Eps15b aligns with the Eps15 sequence. 
The asterisks indicate fully conserved amino acid residues in the Eps15b-speciﬁ  c region.     JCB • VOLUME 180 • NUMBER 6 • 2008  1208
migration of the Eps15 and Eps15R immunoreactive proteins 
( Fig.  3  C ).  In  our hands, the major Eps15R reactive species 
migrated close to the calculated   M  r   of 99 kD for Eps15R, 
whereas previous studies in HeLa cells have reported an appar-
ent   M  r   of 108 for Eps15R (  Coda et al., 1998  ). We believe this 
discrepancy is related to our use of a new SDS-PAGE system 
that yields an apparent faster migration for certain proteins. 
Importantly, the faster migration of Eps15R compared with 
the Eps15-  reactive species excludes the possibility that the 
latter represents Eps15R. 
  Finally, we tried to deplete the cells of Eps15 and Eps15b 
by siRNA-mediated knockdown (  Fig. 3 D  ). By using an siRNA 
oligonucleotide directed against the N-terminal EH domains 
of Eps15, we observed a specifi  c knockdown of the 150-kD pro-
tein, whereas an oligonucleotide directed against the C-terminal 
region common for Eps15 and Eps15b signifi  cantly reduced 
both the 150- and 120-kD    -Eps15  immunoreactive  proteins. 
These knockdown results were reconfi  rmed on the RNA level 
by quantitative real-time PCR using Eps15- and Eps15b-specifi  c 
primers (  Fig. 3 E  ). There was, however, a clear difference in 
effi  ciency of the siRNA oligonucleotides; although 80  –  90% 
of Eps15 was knocked down, the Eps15b expression was only 
reduced by     50%. This was repeatedly observed both at the 
protein and the RNA level and may be caused by differences 
in target accessibility for the siRNA oligonucleotide because 
of differential secondary structures of the Eps15 and Eps15b 
mRNA. Our attempts to specifi  cally knock down the Eps15b 
isoform were unsuccessful, as the short Eps15b-specifi  c se-
quence only allowed the design of suboptimal siRNA oligo-
nucleotides. Collectively, our data suggest that the endogenous 
120-kD protein recognized by anti-Eps15 corresponds to the 
isoform Eps15b. 
  Eps15b forms a tight complex with Hrs 
  Eps15 has been proposed to exist in complex with Hrs on early 
endosomes (  Bean et al., 2000  ;   Bache et al., 2003  ) but its role in 
this complex remains uncharacterized. To explore the possibil-
ity of an interaction between the Eps15b isoform and Hrs, 
we performed an immunoprecipitation with anti-Hrs in HEp-2 
cells. Unexpectedly, we could not detect any Eps15 in the re-
sulting immunoprecipitate, whereas the Eps15b isoform clearly 
coimmunoprecipitated with Hrs (  Fig. 4 A  ). We additionally 
established that the related protein Eps15R did not coimmuno-
precipitate with Hrs ( Fig. 4 B ). These results suggest that Eps15b 
exists in complex with Hrs in HEp-2 cells. The presence of 
Eps15b rather than Eps15 in complex with Hrs was a surprising 
fi  nding, and we therefore wanted to verify the existence of this 
complex using a different approach. To this end, we depleted 
HEp-2 cells of Hrs by siRNA. By comparing the levels of Eps15 
and Eps15b in Hrs-depleted and control cells, we detected lower 
levels of Eps15b in Hrs-depleted cells, whereas Eps15 remained 
unaltered (  Fig. 4 C  ). This result indicates that when cells are 
depleted of Hrs, Eps15b becomes destabilized, a phenomenon 
often observed with proteins coexisting in tight complexes. 
 To further investigate the differential behavior of Eps15 and 
Eps15b, we compared the distribution of the two proteins in 
size exclusion chromatography, whereby protein complexes are 
registered a protein recognized by an Eps15 antibody in NIH 
3T3 cells migrating at 120 kD in addition to the full-length 
Eps15 protein migrating at 150 kD. We confi  rmed this pattern in 
HEp-2 and HeLa cells; and by Western blot analysis of cell 
lysates using three different antibodies generated against the 
C terminus of Eps15, we observed two immunoreactive proteins: 
one major band at 150 kD corresponding to Eps15 and a second 
weaker band at 120 kD (  Fig. 3 A  ). To further explore the possi-
bility that this endogenous 120-kD protein could correspond to 
the Eps15b isoform, we used an antibody raised against the 
N-terminal EH domains of Eps15, which are absent in the Eps15b 
isoform. This antibody recognized the 150-kD Eps15 protein 
but not the 120-kD protein in HeLa cells (  Fig. 3 B  ). To rule out 
that the 120-kD immunoreactive protein was a result of anti-
body cross-reactivity with the related Eps15R, we compared the 
  Figure 3.       Eps15b migrates at 120 kD and is expressed in HeLa and 
HEp-2 cells.   (A) In vitro translated Eps15b was compared with endogenous 
anti-Eps15 immunoreactive protein species from a HeLa cell lysate by 
SDS-PAGE followed by immunoblotting using anti-Eps15 from Santa Cruz 
Biotechnology. The total cell lysate pattern was reconﬁ  rmed with two ad-
ditional antibodies generated against the C terminus of Eps15, anti-Eps15 
No. 2 from Covenance, and anti-Eps15 No. 3 from Abcam. (B) HeLa 
cells were lysed and analyzed by SDS-PAGE and immunoblotting with the 
6G4 antibody raised against the N-terminal region of Eps15. (C) Eps15 
and Eps15R immunoreactive proteins were compared by SDS-PAGE and 
immunoblotting using anti-Eps15R followed by stripping of the membrane 
and reprobing with anti-Eps15. (D) HeLa cells were transfected with siRNA 
oligos targeting Eps15, Eps15, and Eps15b, or a nontargeting control 
RNA duplex as described in Materials and methods. The level of knock-
down was assessed by Western analysis using anti-Eps15 and anti-tubulin. 
Numbers to the right of gel blots indicate molecular mass in kD. (E) The 
level of knockdown was additionally investigated by real-time PCR using 
Eps15- and Eps15b-speciﬁ  c primers.     1209 EPS15B AND ENDOSOMAL SORTING   •   ROXRUD ET AL.
revealed that approximately equal amounts of Eps15 and 
Eps15b were pulled down. To be able to explain the preference 
of Hrs to interact with Eps15b in vivo by differences in bind-
ing affi  nity, we would expect a large difference in binding be-
tween Eps15 and Eps15b in the GST pull-down assays. As we 
did not observe such a difference, we conclude that the appar-
ent preference of Hrs to bind Eps15b in vivo must depend 
upon other factors. The endocytic adaptor AP2 is known to 
exist in complex with the major fraction of Eps15 both in the 
cytosol and at the plasma membrane (  Benmerah et al., 1995  ; 
  Tebar et al., 1996  ), and this could potentially render only 
Eps15b accessible for Hrs and explain the specifi  c formation 
of an Hrs  –  Eps15b complex. To investigate whether AP2 pref-
erentially binds full-length Eps15 in vivo, we performed immuno-
precipitation experiments with anti  –      -adaptin in HEp-2 cells 
(  Fig. 5 B  ). The resulting immunoprecipitate contained large 
amounts of Eps15 and only trace amounts of the Eps15b iso-
form. In summary, our results indicate that although Eps15 and 
Eps15b appear to have similar capacities to interact with Hrs in 
vitro, endogenous AP2 interacts with Eps15, whereas Hrs forms 
a tight complex with the Eps15b isoform. 
separated on the basis of their molecular weight. Size exclusion 
chromatography from A431 total cell lysates revealed a differen-
tial distribution of Eps15 and Eps15b, with Eps15 being detected 
in fractions containing complexes of higher molecular weight 
than Eps15b (  Fig. 4 D  ). In comparison to this, Hrs was detected 
with the same distribution as Eps15b. Even without precisely de-
termining the sizes of the different complexes, this result indi-
cates that Eps15 and Eps15b form separate protein complexes in 
vivo and further pinpoints Eps15b to the Hrs complex. 
  Through the above approaches, we have obtained results 
suggesting that Eps15b rather than Eps15 exists in complex 
with Hrs. However, it has been established that the Eps15 
protein can interact with Hrs (  Bean et al., 2000  ;   Bache et al., 
2003  ) and that both Eps15 and Eps15b contain the domains 
believed to be responsible for the direct interaction with Hrs. 
To further characterize the interaction between Hrs and Eps15/
Eps15b, we performed in vitro pull-down assays using a GST-
Hrs(1  –  500) fusion protein and in vitro translated Eps15 or 
Eps15b. As shown in   Fig. 5 A  , both Eps15 and Eps15b can 
directly interact with Hrs in vitro, and a comparison of the 
amount of Eps15 and Eps15b pulled down with GST-Hrs(1 – 500) 
  Figure 4.       Eps15b forms a complex with Hrs 
in vivo.   (A) HEp-2 cells were lysed and immuno  -
precipitated with anti-Hrs as described in Mate-
rials and methods. The immunoprecipitate was 
analyzed by SDS-PAGE and immunoblotting 
with anti-Eps15 and anti-Hrs. (B) An immuno-
precipitation experiment was performed with 
anti-Hrs as in A and analyzed using anti-
Eps15R and anti-Hrs. (C) HeLa cells were de-
pleted of Hrs by siRNA-mediated knockdown 
and analyzed by SDS-PAGE and immuno-
blotting with anti-Eps15, anti-Hrs, and anti-
tubulin as a loading control. (D) A431 cells 
were subjected to size exclusion chromato-
graphy separating protein complexes after 
their molecular weight, and the resulting frac-
tions were immunoblotted with anti-Eps15 and 
anti-Hrs. Numbers to the right of gel blots indi-
cate molecular mass in kD.     
  Figure 5.       Both Eps15 and Eps15b interact with Hrs in vitro, whereas only Eps15 shows strong interaction with AP2 in vivo.   (A) In vitro translated 
 
35  S-labeled Eps15 and Eps15b were pulled down with recombinant GST-Hrs(1  –  500) or GST immobilized on glutathione-Sepharose beads, and the beads 
were analyzed by SDS-PAGE and autoradiography. (B) Hep-2 cells were lysed and immunoprecipitated with anti-adaptin as described in Materials and 
methods. The immunoprecipitate was analyzed by SDS-PAGE and immunoblotting using anti-Eps15 and anti-adaptin.     JCB • VOLUME 180 • NUMBER 6 • 2008  1210
  Figure 6.       Eps15b is localized to Hrs-positive microdomains on early endosomes.   HeLa cells grown on coverslips were transiently transfected with myc-
Eps15b (A  –  C) or myc-Eps15 (D  –  F) for 20 h, permeabilized before ﬁ  xation, and double labeled with anti-myc (green) and anti-EEA1 (red). Colocalization 
is indicated in yellow. HeLa cells grown on coverslips were transiently transfected with the constitutively active Rab5 mutant Rab5 
Q79L   for 24 h, generating 
enlarged endosomes, followed by a transfection with myc-Eps15b (G  –  I) or myc-Eps15 (J  –  L) for an additional 24 hr. The cells were permeabilized before 
ﬁ  xation and double labeled with anti-Hrs (red) and anti-myc (green). Colocalization is indicated in yellow. Insets show examples of endosomes that are 
sufﬁ  ciently large to enable a distinction between different membrane domains. (M) HEp-2 cells were fractionated as described previously (  Felberbaum-
Corti et al., 2005  ) and the resulting early endosome  –  enriched fraction was analyzed by SDS-PAGE and immunoblotting with anti-Eps15, anti-EEA1, and 
anti  –      -tubulin as loading controls. Bars, 10   μ  m.     1211 EPS15B AND ENDOSOMAL SORTING   •   ROXRUD ET AL.
  Eps15b is localized to early endosomes 
  Eps15 localizes to the cytosol and to clathrin-coated pits at the 
plasma membrane. Additionally, confocal immunofl  uorescence 
analysis has identifi  ed a small pool of an Eps15 immunoreactive 
protein present on early endosomes, colocalizing with Hrs and 
clathrin (  Bache et al., 2003  ). However, the polyclonal antibody 
used in this analysis cannot distinguish between Eps15 and 
Eps15b, and we therefore wanted to investigate the specifi  c 
intracellular localization of Eps15b. Because our attempt to 
generate an Eps15b-specifi  c antibody failed (unpublished data), 
we transiently transfected HeLa cells with myc epitope  –  tagged 
Eps15b. As shown in   Fig. 6 (A  –  C  ), Eps15b colocalized with the 
early endosomal antigen 1 (EEA1) and did not display any 
plasma membrane staining. This indicates that Eps15b is spe-
cifi  cally localized to early endosomes. In cells expressing myc-
tagged Eps15, we observed Eps15 in punctuate structures at the 
plasma membrane and little colocalization with EEA1 (  Fig. 6, 
D  –  F  ). However, in cells expressing large amounts of myc-
Eps15, a substantial fraction of the protein became localized to 
endosomal structures (unpublished data), indicating that there is 
a fi  nely regulated balance between Eps15 and Eps15b regarding 
their intracellular localization. By transfecting cells with the 
constitutively active mutant of the small GTPase Rab5, Rab5 
Q79L , 
we generated enlarged endosomes, where distinct endosomal 
microdomains can be observed by confocal immunofl  uorescence 
microscopy. Myc-tagged Eps15b was found to localize to Hrs-
positive microdomains of these enlarged endosomes (  Fig. 6, 
G  –  I  ), which is in line with the hypothesis that Eps15b and Hrs 
coexist in a complex, whereas Eps15 showed punctuate plasma 
membrane localization (  Fig. 6, J  –  L  ). To obtain more physiolog-
ically relevant information about the distribution of Eps15 and 
Eps15b, we purifi  ed fractions enriched in early endosomes from 
HEp-2 cells ( Felberbaum-Corti et al., 2005 ). Western blot analy-
sis revealed the resulting fractions to be highly enriched with 
Eps15b relative to Eps15 (  Fig. 6 M  ). This supports the confocal 
immunofl  uorescence analysis and indicates that Eps15b is 
localized to early endosomes. 
  Eps15b mediates endosomal sorting 
of the EGFR 
  The Hrs complex constitutes an essential sorting step for ubiq-
uitinated cargo destined for lysosomal degradation, and both 
overexpression and depletion of Hrs lead to impaired degrada-
tion of internalized EGFR (  Raiborg et al., 2001a  ;   Bache et al., 
2003  ;   Petiot et al., 2003  ). To address the possible function of 
Eps15b in endosomal protein sorting, we fi  rst asked whether 
overexpression of Eps15 or Eps15b affects degradation of inter-
nalized EGFRs. Interestingly, when we overexpressed myc 
epitope  –  tagged Eps15b, degradation of activated EGFR was 
signifi  cantly inhibited (  Fig. 7 A  ), whereas endocytosis of the re-
ceptor remained unaltered (  Fig. 7 B  ) as measured by confocal 
immunofl  ourescence microscopy. Furthermore, the EGFR ac-
cumulated on early endosomes in the myc-Eps15b  –  expressing 
cells (  Fig. 7, C  –  F  ) similarly to Hrs overexpression. In contrast, 
overexpressing myc-Eps15 did not alter EGFR degradation 
(  Fig. 7, A and G  –  J  ). These results show that overexpression of 
Eps15b causes similar inhibitory effects on EGFR degradation 
as overexpression of Hrs, which is consistent with the possibil-
ity that Eps15b plays a role in EGFR sorting. 
  To obtain a more direct evidence for a functional role of 
Eps15b in the Hrs complex, we transfected cells with an siRNA 
oligonucleotide targeting Eps15 and Eps15b and measured the 
amount of EGFR remaining in the cells at different time points 
after stimulation with EGF by confocal immunofl  ourescence 
microscopy. In the resulting Eps15- and Eps15b-depleted cells, 
there was only a minor decrease in endocytosed EGFRs (  Fig. 8 A  ), 
which was in line with previous studies (  Huang et al., 2004  ; 
  Sigismund et al., 2005  ). This indicates that neither Eps15 nor 
Eps15b are essential for EGFR internalization. Interestingly, 
however, when we assayed degradation of EGFRs, we observed 
a strongly delayed degradation in Eps15/Eps15b-depleted cells 
(  Fig. 8 B  ). This indicates that Eps15 and/or Eps15b is involved 
in ligand-induced degradation of the EGFR independently of 
the internalization step. 
  To verify these results biochemically and determine the 
relative importance of Eps15 and Eps15b, we studied the rates 
of internalization and degradation of  
125  I-labeled EGF in control 
cells versus Eps15/Eps15b-depleted cells or cells depleted of 
only Eps15. Consistent with previous studies and with our con-
focal microscopy analysis, the rate of [ 
125 I]EGF  internalization 
was slightly reduced in cells depleted of Eps15, and the same 
was the case in cells depleted of both Eps15 and Eps15b ( Fig. 8 C ). 
More importantly, although depletion of Eps15 had no effect on 
degradation of endocytosed [ 
125  I]EGF, the additional depletion 
of Eps15b markedly inhibited [ 
125  I]EGF degradation (  Fig. 8 D  ). 
This indicates that Eps15b is required for effi  cient degradation 
of endocytosed EGF. 
  Because depletion of Hrs causes increased recycling of 
[ 
125  I]EGF (  Raiborg et al., 2008  ), we next asked if the same is 
the case when Eps15b is knocked down. Interestingly, our bio-
chemical analysis showed that recycling of [ 
125 I]EGF  was 
strongly increased in cells depleted of both Eps15 and Eps15b, 
whereas cells only depleted of Eps15 showed the same rates of 
[ 
125  I]EGF recycling as cells treated with a control RNA duplex 
(  Fig. 8 E  ). This indicates that depletion of Eps15b, similarly to 
that of Hrs, shifts the traffi  cking of internalized EGF from the 
degradative to the recycling pathway. Collectively, our results 
are consistent with the possibility that Eps15b functions in a 
complex that recognizes ubiquitinated receptors in the endo-
somal membrane, thereby promoting their degradation and pre-
venting their recycling. 
  Reintroduction of siRNA-resistant Eps15b 
rescues the impaired EGFR degradation in 
Eps15/Eps15b-depleted cells 
  Because siRNA oligonucleotides may sometimes cause off-
target effects, we found it important to verify that the inhibitory 
effect of the siRNA against Eps15/Eps15b on EGFR degrada-
tion was specifi  cally caused by knockdown of Eps15b. For this 
purpose we transfected cells depleted of Eps15 and Eps15b with 
siRNA-resistant myc-Eps15b or myc-Eps15 and assayed degra-
dation of the EGFR by confocal immunofl  uorescence micros-
copy. Knowing that high-level overexpression of myc-Eps15b 
inhibits EGFR degradation by itself (  Fig. 7 A  ), we studied cells JCB • VOLUME 180 • NUMBER 6 • 2008  1212
Although we have been unable to identify direct Eps15b coun-
terparts in invertebrates and lower eukaryotes, it is worth noting 
that such organisms often contain several Eps15-like molecules 
that might potentially play differential roles in endocytic traf-
fi  cking. Although Eps15 has previously been suggested to local-
ize to the Hrs complex on early endosomes, our results indicate 
that the Eps15b isoform is the main Eps15-related protein spe-
cies present in this complex, and in contrast to full-length Eps15, 
it does not localize to clathrin-coated pits and interacts with 
AP2 only to a minor extent. Our results further indicate that 
Eps15b, in contrast to Eps15, is required for effi  cient degradative 
expressing low amounts of myc-Eps15b. Importantly, although 
reexpression of myc-Eps15 in siRNA-treated cells did not res-
cue the inhibited EGFR degradation, reintroducing low levels 
of Eps15b to these cells did (  Fig. 9, A  –  C  ). These results indicate 
that it is indeed the Eps15b isoform that is required for proper 
down-regulation of the EGFR. 
  Discussion 
  In this work, we have identifi  ed a novel Eps15 isoform that 
is conserved in birds and mammals and named it Eps15b. 
  Figure 7.       Overexpression of myc-Eps15b leads to an impairment of EGFR down-regulation independently of endocytosis.   (A) HeLa cells grown on cover-
slips were transfected with myc-Eps15b or myc-Eps15 for 24 h and subjected to EGF stimulation for 15 or 120 min. The cells were permeabilized, ﬁ  xed, 
and stained with anti-EGFR. EGFR degradation was analyzed by quantitating the amount of undegraded EGFR remaining in the cells at t = 120 min rela-
tive to t = 15 min by confocal immunoﬂ  uorescence microscopy. Error bars represent standard errors (control cells,   n   = 18; Eps15-expressing cells,   n   = 10; 
and Eps15b-expressing cells,   n   = 11). (B) HeLa cells grown on coverslips were transfected with myc-Eps15b for 24 h and stimulated with EGF for 5 min. 
The EGFR remaining on the cell surface was removed by a 5-min incubation with stripping buffer followed by permeabilization, ﬁ  xation, and staining with 
anti-EGFR. Internalized EGFR was quantitated by confocal immunoﬂ  uorescence microscopy and transfected cells were detected with anti-myc. The ﬁ  gure 
shows the mean of three independent experiments and error bars represent standard deviations. (C  –  F) myc-Eps15b  –   or (G  –  J) myc-Eps15  –  expressing cells 
were subjected to the EGFR degradation assay as in A and triple-stained with anti-EEA1 (blue), anti-myc (red), and anti-EGFR (green). Triple colocalization 
is indicated in white. Arrows indicate transfected cells. Insets show magniﬁ  ed examples of colocalization.     1213 EPS15B AND ENDOSOMAL SORTING   •   ROXRUD ET AL.
The Eps15b isoform has the same apparent molecular weight as a 
putative Eps15 isoform discovered by   Fazioli et al. (1993)   in ro-
dent NIH 3T3 cells. Although we have not addressed the specifi  c 
identity of the protein identifi  ed by Fazioli et al., it is not unlikely 
that this protein could correspond to the Eps15b isoform. In their 
work, they observed this 120-kD protein as a doublet band, simi-
larly to the Eps15 doublet band at 150 kD, which was later shown 
to correspond to the ubiquitinated and nonubiquitinated form of 
Eps15. Furthermore, both the 150-kD Eps15 protein and the 120-kD 
protein were tyrosine phosphorylated upon EGF stimulation. Thus, 
the Eps15b protein may share the general characteristics of EGF-
induced phosphorylation and monoubiquitination with Eps15. 
  Although an Eps15 reactive species has previously been 
identifi  ed as a component of the Hrs complex on early endo-
somes, we have gathered data indicating that the Eps15b iso-
form is the main product of the   EPS15   gene stably associated 
with Hrs. In vitro binding assays further indicated that the spe-
cifi  c formation of an Hrs  –  Eps15b complex is based upon other 
factors than differences in interaction affi  nity. The fact that 
endosomal sorting of EGFRs. We propose that Eps15 and Eps15b 
function in complexes that mediate cargo recognition at the 
plasma membrane and the endosome, respectively (  Fig. 10  ). 
  The Eps15b isoform has not previously been characterized, 
and by combining sequence information available in public data-
bases and experimental approaches, we demonstrate that Eps15b 
is evolutionarily conserved and expressed in several human cell 
types. The Eps15b isoform contains 32 amino acid residues in its 
N-terminal end, which in the full-length Eps15 are spliced out 
from the precursor mRNA as a part of intron 12. Various bioinfor-
matic search tools did not identify any known motives within this 
sequence but these 32 residues could nevertheless give the Eps15b 
protein different properties compared with full-length Eps15. 
Even more important for the properties of Eps15b might be the 
lack of the three N-terminal EH domains, which in full-length 
Eps15 are essential for its participation in the complex network 
of multiple protein  –  protein interactions at the clathrin-coated 
pits. The capacity of Eps15b to participate in protein  –  protein 
interactions is consequently signifi  cantly smaller than for Eps15. 
  Figure 8.       Eps15b mediates down-regulation of the EGFR independently of endocytosis.   (A) HeLa cells grown on coverslips were depleted of Eps15 and 
Eps15b by siRNA-mediated knockdown and stimulated with EGF for 5 min at 37  °  C to induce EGFR internalization. The EGFR remaining on the cell sur-
face was removed by stripping buffer followed by permeabilization, ﬁ  xation, and staining with anti-EGFR. Internalized EGFR was quantitated by confocal 
immunoﬂ  uorescence microscopy. The ﬁ  gure shows the mean of three independent experiments and the error bars represent SEM. (B) Eps15/Eps15b-
depleted HeLa cells grown on coverslips were subjected to EGF stimulation for 15, 60, 120, or 180 min. The cells were stained with anti-EGFR. EGFR 
degradation was analyzed by quantitating the amount of undegraded EGFR remaining in the Eps15/Eps15b knockdown and in cells treated with a control 
RNA duplex at each time point by confocal immunoﬂ  uorescence microscopy. Error bars represent SEM (control: 15 min,   n   = 22; 60 min,   n   = 22; 120 min, 
  n   = 22; 180 min,   n   = 27; and Eps15+Eps15b siRNA: 15 min,   n   = 23; 60 min,   n   = 24; 120 min,   n   = 23; and 180 min,   n   = 21). (C) Internalization of 
[ 
125  I]EGF in HeLa cells depleted of Eps15/Eps15b. Eps15/Eps15b-depleted cells were seeded in 24-well plates and an internalization assay of [ 
125  I]EGF 
(1 ng/ml) was preformed as described in Materials and methods. Internalized [ 
125  I]EGF was calculated as counts per minute of internalized [ 
125  I]EGF divided 
by counts per minute of surface-localized [ 
125  I]EGF. The data represent six independent experiments with four parallels. The difference between control and 
both Eps15- and Eps15/Eps15b-depleted cells was statistically signiﬁ  cant at time points 5, 7.5, and 10 min (P   <   0.05). Error bars represent SEM. (D and E) 
Degradation (D) and recycling (E) of [ 
125  I]EGF in Eps15/Eps15b-depleted cells. Cells were incubated with [ 
125  I]EGF (1 ng/ml) on ice for 15 min then washed 
with PBS before preheated medium was added to the cells and chased for the indicated time period at 37  °  C. Upon incubation, the medium was divided into 
acid-soluble and -precipitable fractions representing degraded and recycled [ 
125  I]EGF, respectively. The cell-associated radioactivity represented internalized 
and cell-associated [ 
125  I]EGF. The data are shown as a percentage of total initially bound [ 
125  I]EGF and represent six independent experiments with four 
parallels. There was no statistically signiﬁ  cant difference between control and Eps15-depleted cells with regard to degradation and recycling, but for Eps15b 
depleted cells, the difference to control cells was statistically signiﬁ  cant (P   <   0.05) for all time points (60, 120, and 180 min). Error bars represent SEM.     JCB • VOLUME 180 • NUMBER 6 • 2008  1214
peats capable of interacting with AP2, these results raise the 
question of why AP2 does not bind Eps15b in vivo. One possible 
explanation could be provided by differences in oligomerization 
status between the Eps15 and Eps15b isoforms. Eps15 exists as 
dimers and tetramers in cells, although it is unclear whether 
dimer or tetramer is the predominant form (  Tebar et al., 1997  ). 
The formation of antiparallel tetramers depends on the N- and 
C-terminal domains of the protein (  Cupers et al., 1997  ). As Eps15b 
Eps15 constitutively interacts with AP2 may provide a possible 
explanation, as Hrs and AP2 are not able to bind Eps15 simulta-
neously (  Bean et al., 2000  ). Immunoprecipitation experiments 
established that AP2 mainly interacts with Eps15 in vivo, and 
only small amounts of Eps15b were coimmunoprecipitated with 
AP2. Consequently, with Eps15 constitutively bound to AP2, 
only Eps15b will be accessible to form a complex with Hrs. 
Given the fact that Eps15b and Eps15 both contain the DPF re-
  Figure 9.       Eps15b is essential for EGFR deg-
radation.   HeLa cells were treated with Eps15- 
and Eps15b-speciﬁ   c siRNA oligonucleotides 
and at the same time transiently transfected 
with siRNA-resistant myc-Eps15 (A) or myc-
Eps15b (B). The cells were stimulated with 
50 ng/ml EGF for 15 min and then washed 
and incubated for 2 h in the presence of 
cycloheximide to allow degradation of inter-
nalized EGFRs. The cells were then prepared 
for confocal immunoﬂ  uorescence microscopy 
and labeled with anti-EGFR (green) and anti-
myc (red) antibodies. (A) Eps15- and Eps15b-
depleted cells transfected with myc-Eps15 
(arrows) showed inhibited EGFR degradation 
similar to Eps15/Eps15b-depleted neighbor-
ing cells. (B) Eps15- and Eps15b-depleted 
cells transfected with myc-Eps15b (arrows) 
showed normal degradation of EGFR as com-
pared with Eps15/Eps15b-depleted neigh-
boring cells in which the degradation was 
inhibited. White lines indicate the cell bor-
ders. Bar, 10   μ  m. (C) The amount of EGFR 
remaining after 2 h of chase was quantiﬁ  ed 
as described in Materials and methods and is 
represented as percentage of the total amount 
of internalized EGFR after 15 min. Control 
cells were treated with a nontargeting RNA 
duplex. In total, 100  –  300 cells were mea-
sured for each treatment. Error bars show   ±   
SEM from four independent experiments.     1215 EPS15B AND ENDOSOMAL SORTING   •   ROXRUD ET AL.
  Which mechanism could account for the inhibited deg-
radation of EGFRs observed in Eps15b-depleted cells? Previ-
ous studies have shown that depletion of Hrs or ESCRT-I 
enhances recycling of endocytosed EGF and its receptor, 
whereas this is not the case with depletion of ESCRT-II and 
ESCRT-III (  Bache et al., 2006  ;   Raiborg et al., 2008  ). Follow-
ing the fate of internalized [ 
125  I]EGF, we observed that re-
cycling of this ligand was strongly enhanced in cells treated 
with siRNA against Eps15 + Eps15b but not in cells only de-
pleted of Eps15. Thus, depletion of Eps15b results in the 
same net effect as depletion of Hrs, which is consistent with 
the idea that these proteins function in the same endosomal 
sorting complex. We speculate that the role of this complex 
may be to recognize ubiquitinated cargoes such as activated 
EGFRs in the endosomal membrane, thereby preventing their 
recycling to the plasma membrane. 
  Several alternative mechanisms have been suggested for 
the role of Eps15 in endocytosis. One hypothesis suggests that 
Eps15 recruits ubiquitinated receptors to the rims of clathrin-
coated pits by interacting with the ubiquitin tag through its 
UIMs (  Polo et al., 2002  ;   Riezman, 2002  ;   de Melker et al., 2004  ; 
  Stang et al., 2004  ). Eps15 has also been found to be involved 
in clathrin-dependent endocytosis of nonubiquitinated EGFRs 
as well as clathrin-independent endocytosis of ubiquitinated 
EGFRs (  Sigismund et al., 2005  ), which suggests that the func-
tion of Eps15 extends beyond clathrin- and ubiquitin-dependent 
receptor traffi  cking. Although ubiquitination of membrane pro-
teins is a dominant signal for their endosomal sorting, only a 
few proteins have been shown to use ubiquitin as an endocytosis 
signal (  Hicke and Dunn, 2003  ;   Raiborg et al., 2003  ). The func-
tion of the Eps15b isoform in the Hrs complex could be to 
increase the avidity of the complex for ubiquitinated cargo. 
Recently, it was shown in   Drosophila melanogaster   that Eps15 
is required for synaptic vesicle endocytosis and that the loss of 
Eps15 reduces the amount of dynamin and Dap160/Intersectin 
at the neuromuscular junctions, which indicates a role of Eps15 
in maintaining dynamin at the site of endocytosis (  Koh et al., 
2007  ). Eps15 has additionally been shown to stimulate clathrin 
lacks the N-terminal domain, it is not able to form tetramers but 
may still form dimers. This could possibly explain the reduced 
AP2 binding because AP2 has been shown by immunoprecipi-
tation experiments to bind tetramers of Eps15 signifi  cantly more 
effi  ciently than dimers (  Tebar et al., 1997 ). A  second  possible ex-
planation is that the interaction between AP2 and Eps15 is me-
diated or enhanced by an unknown protein, potentially through 
the EH domains that would exclude the Eps15b isoform from 
the interaction. 
  Our combined biochemical and immunofl  uorescence-
based approaches indicate that the Eps15b isoform is localized 
to early endosomes and not to clathrin-coated pits. It has previ-
ously been shown that an Eps15 deletion mutant lacking the 
second and third EH domains loses correct targeting to clathrin-
coated pits and instead is cytosolic (  Benmerah et al., 1999  ). It is 
therefore not surprising that Eps15b, which lacks all three EH 
domains, is not localized to clathrin-coated pits, although its lo-
calization to endosomes was unanticipated. Eps15 mainly local-
ized to clathrin-coated pits in our assays, but Eps15 may also be 
localized to endosomal compartments during EGF stimulation 
of cells. It has been suggested that Eps15 may be internalized 
together with the clathrin-coated vesicles and further trans-
ported to early endosomes together with the EGFR, or alterna-
tively, dissociates from the forming clathrin-coated vesicle 
followed by a retargeting to endosomes (  Tebar et al., 1996  ; 
  van Delft et al., 1997  ;   Cupers et al., 1998  ;   Torrisi et al., 1999  ). 
Although controversial, these remain putative mechanisms for 
Eps15 localization to endosomal compartments. However, some 
of these studies have been performed with antibodies that can-
not distinguish between Eps15 and Eps15b and it is therefore 
unclear which isoform contributes to the distinct parts of the 
distribution patterns. Our studies indicate that Eps15b is the 
predominant Eps15 isoform on endosome membranes and that 
the immunolabeling within bilayered coats on endosomes (  Fig. 1  ) 
most likely represents Eps15b. 
  To address the functional role of Eps15b in the Hrs 
complex, we used both overexpression and siRNA-based ap-
proaches. Overexpression of Eps15b led to impaired EGFR deg-
radation. This phenotype is identical to what is observed in cells 
overexpressing Hrs and suggests that the Eps15b isoform plays 
a role in endosomal protein sorting as a part of the Hrs complex. 
The effect could be caused by the accumulation of Hrs on early 
endosomes (unpublished data). Importantly, overexpression of 
Eps15 did not lead to any inhibition of EGFR degradation, which 
suggests that the role in degradative EGFR sorting is specifi  c to 
Eps15b. Because the mechanism by which overexpression of 
Eps15b or Hrs prevents EGFR degradation is not clear, we also 
sought to measure degradation of the EGFR in cells depleted of 
Eps15b. Because we were unsuccessful in generating an siRNA 
oligonucleotide that specifi  cally knocked down Eps15b, we per-
formed the assay using an oligonucleotide targeting both Eps15 
and Eps15b. In cells depleted of Eps15 and Eps15b but not in 
cells depleted of only Eps15, the degradation of the EGFR was 
impaired. Importantly, this inhibitory phenotype was rescued by 
the reintroduction of low levels of siRNA-resistant Eps15b but 
not Eps15. This indicates that Eps15b is required for degradation 
of endocytosed EGFRs. 
  Figure 10.       Differential functions of Eps15 and Eps15b in EGFR trafﬁ  cking.   
Together with AP2, Epsin, and several other proteins, Eps15 mediates 
internalization of activated EGFRs. The endocytosed receptors and their 
ligands are then transported to early endosomes, where they are retained 
in the bilayered clathrin coat by Hrs, STAM, and Eps15b. They are further 
escorted into intraluminal vesicles of multivesicular endosomes by ESCRT 
I  –  III and ﬁ  nally degraded in lysosomes (not depicted).     JCB • VOLUME 180 • NUMBER 6 • 2008  1216
using FuGENE 6 (Roche) or Effectene (QIAGEN) according to the manufac-
turer  ’  s instructions. Transfection of HeLa cells with siRNA oligonucleotides 
(200 nM) was performed as described previously (  Elbashir et al., 2002  ) 
using Oligofectamine (Invitrogen). 
  Antibodies 
  Rabbit anti-Eps15 (raised against a peptide in the C terminus; C-20) and 
mouse anti  –      -adaptin (C8) were obtained from Santa Cruz Biotechnology, 
Inc. Two additional Eps15 antibodies were used, a rabbit anti-Eps15 ob-
tained from Abcam (raised against amino acids 539  –  896) and a rabbit 
anti-Eps15 (C terminus; 569  –  896) obtained from Covance. The N-terminal 
mouse anti-Eps15 antibody 6G4 (  Benmerah et al., 1995  ) was a gift from 
A. Benmerah (Institut Cochin, Paris, France). The rabbit anti-Eps15R anti-
body was a gift from S. Polo (Instituto Firc di Oncologia Molecolare, Milan, 
Italy). Sheep anti-EGFR was obtained from Fitzgerald. Rabbit anti    bodies 
against recombinant Hrs have been described previously (  Raiborg et al., 
2001a  ). Mouse anti-myc antibodies were derived from 9E10 hybridoma 
cells. Human anti-EEA1 antiserum (  Mu et al., 1995  ) was a gift from 
B.-H. Toh (Monash University, Melbourne, Australia). The mouse mono-
clonal antibody against     -tubulin was obtained from Sigma-Aldrich. Cy2-, 
Cy3-, and horseradish peroxidase  –  labeled secondary antibodies were 
obtained from Jackson ImmunoResearch Laboratories. 
  Immunoprecipitation experiments 
  HEp-2 cells were lysed (lysis buffer: 25 mM Hepes, pH 7.2, 125 mM po-
tassium acetate, 2.5 mM magnesium acetate, 5 mM EGTA, 0.5% Igepal 
CA-630, 1 mM dithiothretiol, and mammalian protease inhibitor mixture) 
and precleared by incubating at 4  °  C for 1 h with 50   μ  l protein A  –  Sepha-
rose (GE Healthcare) preincubated with rabbit or mouse IgG followed by 
an incubation at 4  °  C for 1 h with 50   μ  l protein A  –  Sepharose preincubated 
with 5   μ  l anti-Hrs serum or 3   μ  g anti  –      -adaptin. Immunoprecipitates were 
washed and analyzed by SDS-PAGE (precast gels were obtained from 
Thermo Fisher Scientiﬁ  c) and immunoblotting. 
  Real-time PCR 
  Total RNA was isolated from HeLa cells 3 d after siRNA transfection using the 
Aurum Total RNA mini kit (Bio-Rad Laboratories) and cDNA was synthesized 
using the iScript cDNA synthesis kit (Bio-Rad Laboratories) as described by the 
manufacturer. Real-time PCR was performed with manually designed Ep15- 
and Eps15b-speciﬁ  c primers (Eps15b forward primer, 5    -CTTGCATTGTTT-
GCTGGT-3    ; Eps15b reverse primer, 5    -CTTGAAGATCCTBGAACCTC-3    ; 
Eps15 forward primer, 5    -CCTGTTGCAGATTTCTCTG-3    ; and Eps15 reverse 
primer, 5    -TCATCTTGAAGATCCTGAAC-3    ) and tyrosyl-tRNA synthetase 
(YARS) as an internal reference control (YARS forward primer, 5    -GCCTA-
CCCAGATCCCTCAAAG-3    ; YARS reverse primer, 5    -ATGACCTCCTCTG-
GTTCTGAATTC-3    ). One primer out of each primer set was designed spanning 
an intron-exon boundary to avoid ampliﬁ  cation of contaminating DNA. The 
ampliﬁ  cations were performed with a LightCycler 480 instrument (Roche) ac-
cording to the manufacturer  ’  s instructions. The quantiﬁ  cation values of Eps15/
Eps15b relative to YARS were calculated using the LightCycler relative quanti-
ﬁ  cation software. Standard curves were generated to calculate the efﬁ  ciency 
of each primer set and then integrated into the data analysis. 
  GST pull-down assays 
  Eps15 and Eps15b were in vitro transcribed and translated with the TNT 
T7 Coupled Reticulocyte lysate system (Promega) as described by the 
manufacturer in the presence of [ 
35  S]methionine (PerkinElmer). The GST-
Hrs fusion protein was expressed by transforming   Escherichia coli   BL-21 
(DE3) with the construct, and protein expression was induced by 0.3 mM 
isopropyl-1-thio-    -  D  -galactopyranoside for 3 h at 37  °  C and the concentra-
tion was measured by Coommassie staining. GST or GST-Hrs was bound 
to 25-  μ  l aliquots of glutathione-Sepharose (GE Healthcare) at room tem-
perature for 60 min, the beads were washed with assay buffer (25 mM 
Hepes, pH 7.2, 125 mM potassium acetate, 2.5 mM magnesium ace-
tate, 5 mM EGTA, and 1 mM dithiothretiol), and equal amounts of in vitro 
translated Eps15 or Eps15b was added. After rotation at 4  °  C for 60 min, 
the beads were washed with assay buffer and analyzed by SDS-PAGE 
and autoradiography. 
  Endosome puriﬁ  cation 
  A fraction enriched in early endosomes was generated from HEp-2 cells as 
described previously (  Felberbaum-Corti et al., 2005  ). 
  Size exclusion chromatography 
  A431 cells were lysed as described previously and lysates were ﬁ  ltered 
through a 0.22-  μ  m membrane (Millipore). The lysate was fractionated on 
assembly at clathrin-coated pits (  Morgan et al., 2003  ). The Hrs-
positive microdomains on early endosomes contain clathrin 
coats, and to address whether the Eps15b isoform stimulates 
clathrin assembly in these microdomains, we investigated the 
localization of clathrin on endosomes in cells depleted of Eps15 
and Eps15b and in cells expressing large amounts of myc-Eps15b. 
We could not detect any signifi  cant effects (unpublished data), 
which suggests that Eps15 proteins are not essential for clathrin 
assembly on early endosomes. 
  In conclusion, we have identifi  ed Eps15b as an evolution-
arily conserved and functionally distinct isoform of Eps15. Our 
results suggest that Eps15b, in contrast to Eps15, constitutes a 
stable part of the Hrs complex and mediates endosomal sorting 
of EGFRs (  Fig. 10  ). In future experiments, it will be interesting 
to elucidate the exact functions of Hrs, STAM, and Eps15b in 
this endosomal sorting complex. 
  Materials and methods 
  Plasmid constructs and siRNA 
  The Eps15b full-length cDNA clone DKFZp686D16141 was obtained from 
imaGenes and the myc-Eps15b construct was generated by PCR ampliﬁ  ca-
tion and cloning into pcDNA3-myc. The myc-Eps15 construct was gener-
ated by subcloning the cDNA into pcDNA3-myc. The pcDNA3-Rab5 
Q79L   
has been described previously (  Stenmark et al., 1994  ). A GST-Hrs (resi-
dues 1  –  500 of Hrs) construct was generated by subcloning the cDNA into 
pGEX-6P (GE Healthcare). The siRNA oligos against the C terminus of 
Eps15 and Eps15b and the N terminus of Eps15 have been described pre-
viously (  Huang et al., 2004  ;   Sigismund et al., 2005  ). The sense sequence 
of the Eps15-speciﬁ  c RNAi was GAGUUUGGGAGUUGAGUGA and the 
sense sequence of the Eps15/Eps15b speciﬁ  c RNAi was AAACGGAGCU-
ACAGAUUAU. A nontargeting siRNA oligo obtained from Dharmacon 
was used as a negative control. A PCR primer was designed to generate 
an siRNA-resistant Eps15b with the sequence GCATTCTTGTAAATGGC-
GCCACTGATTATTGCAGCCTC. The siRNA speciﬁ  c for Hrs has been de-
scribed previously (  Bache et al., 2003  ). 
  Confocal immunoﬂ  uorescence microscopy 
  HeLa cells grown on coverslips were permeabilized with 0.05% saponin, 
ﬁ  xed with 3% paraformaldehyde, and stained for ﬂ  uorescence microscopy 
as described previously (  Simonsen et al., 1998  ). Coverslips were ana-
lyzed at 25  °  C with a confocal microscope (LSM 510 META; Carl Zeiss, 
Inc.) equipped with Plan Apochromat 63  ×   1.4 NA and Neo Fluar 100  ×   
1.45 NA oil immersion objectives (both from Carl Zeiss, Inc.). Appropriate 
emission ﬁ  lter settings were included to exclude bleed-through effects. 
Images were acquired with the LSM 510 software (version 3.2; Carl Zeiss 
Inc.) and processed with Photoshop (version 7.0; Adobe). 
  Immunoelectron microscopy 
  HEp-2 and HeLa cells were serum-starved (0.5% FCS) 20 h before incu-
bation with EGF. Precooled cells (left on ice) were incubated with EGF 
(60 ng/ml in MEM without bicarbonate and with 0.1% BSA) on ice for 
15 min followed by washing three times in ice-cold PBS to remove 
unbound ligand. Subsequently, the cells were chased in ligand-free 
MEM without bicarbonate at 37  °  C for 15 min before ﬁ  xation and prepa-
ration for cryosectioning and immunolabeling as described previously 
(  Myromslien et al., 2006  ). For single labeling, thawed cryosections 
were labeled using rabbit anti-Eps15 (C terminus) from Covance Re-
search Products followed by 15-nm protein A  –  gold (obtained from G. 
Posthuma, Utrecht University, Utrecht, Netherlands). In double-labeling 
experiments, labeling for Eps15 was followed by incubation with free 
protein A before labeling for Hrs followed by 10 nm protein A  –  gold. 
Sections were examined using a transmission electron microscope 
(CM120; Philips) with a transmission electron microscopy soft imaging 
system (Megaview II; Olympus). 
  Cell culture and transfection 
  HeLa and HEp-2 cell cultures were maintained as described by the Ameri-
can Type Culture Collection. pcDNA3 constructs were transfected into cells 1217 EPS15B AND ENDOSOMAL SORTING   •   ROXRUD ET AL.
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a Sepharose 200 gel ﬁ  ltration column using the   Ä  kta Explorer fast protein 
liquid chromatography system (GE Healthcare). The resulting fractions were 
TCA precipitated, resuspended in SDS loading buffer, and analyzed by 
SDS-PAGE followed by immunoblotting with Eps15 and Hrs antibodies. 
  Assay of EGFR degradation and internalization 
  HeLa cells were depleted of Eps15 and Eps15b by siRNA-mediated 
knockdown for 72 h, seeded onto coverslips, and cultured for an addi-
tional 48 hr. Alternatively, untreated HeLa cells were transfected with 
myc-Eps15b or myc-Eps15. EGFR degradation was assayed by incubat-
ing the cells for 15, 60, 120, or 180 min after stimulating with 100 ng/ml 
EGF in the presence of 10   μ  g/ml cycloheximide, followed by ﬁ  xation 
and staining with anti-EGFR. EGFR internalization was assayed by incu-
bating siRNA cells with 100 ng/ml EGF for 5 min followed by a 5-min 
incubation with stripping buffer (2 M NaCl and 20 mM NaAc, pH 4.0) 
at 37  °  C to remove all EGFR remaining at the cell surface, and ﬁ  nally ﬁ  xa-
tion and staining with anti-EGFR. The amount of undegraded or inter-
nalized EGFR was quantitated by immunoﬂ   ourescence microscopy. 
Coverslips were scanned with a LSM 510 Meta microscope at ﬁ  xed in-
tensity settings below pixel value saturation, and     20 cells were quanti-
tated from each sample at each time point. The images were processed 
with the histogram function in the LSM software. The experiments were 
independently repeated with similar results. 
  Assay of rescuing EGFR degradation with reexpressed Eps15b 
  HeLa cells were ﬁ  rst depleted of endogenous human Eps15 and Eps15b by 
siRNA for 72 h. The siRNA-treated cells were then seeded onto coverslips in 
a 24-well tissue culture dish and transfected the following day with siRNA-
resistant pcDNA3-myc-Eps15b or pcDNA3-myc-Eps15 for 17 h. The trans-
fected cells were preincubated with 20   μ  g/ml cycloheximide for 1 h before 
incubation with 50 ng/ml EGF for 15 min in the presence of 20   μ  g/ml cy-
cloheximide. The cells were washed in PBS and incubated for 2 h in DME 
supplemented with 10% FCS and 20   μ  g/ml cycloheximide to allow EGFR 
degradation. The cells were then processed for confocal microscopy using 
anti-myc and anti-EGFR antibodies. For the quantiﬁ  cation of cell-associated 
EGFR, confocal images of cells were recorded at ﬁ  xed intensity settings be-
low pixel value saturation and analyzed by post-image processing. All pixel 
values above background level (deﬁ  ned as mean values obtained in un-
labeled cells) were integrated for each cell using the histogram function in the 
LSM software. The experiment was repeated four times and in total, 100  –
  300 cells were analyzed from each category. Because high-level overexpres-
sion of Eps15b inhibits EGFR trafﬁ  cking (this paper), only cells expressing 
low levels of myc-tagged Eps15b constructs (deﬁ  ned as below a threshold 
value corresponding to close to endogenous levels using the palette function 
of the LSM software) were included in the analysis. 
  Internalization of [ 
125  I]EGF 
  Internalization of [ 
125  I]EGF was measured upon incubation with 1 ng/ml 
[ 
125  I]EGF (GE Healthcare) as described previously (  Johannessen et al., 
2006  ). The ratio of internalized to surface-bound EGF was plotted as a 
function of time. 
  Assay for degradation and recycling of [ 
125  I]EGF 
  Analysis of degradation and recycling of [ 
125  I]EGF was preformed essen-
tially as described previously (  Sorkin et al., 1988  ;   Skarpen et al., 1998  ). 
In brief, 1 ng/ml [ 
125  I]EGF in Hepes buffer was added to cells on ice for 
15 min. Then the cells were washed three times with ice-cold PBS to remove 
unbound [ 
125  I]EGF. The cells were further chased in Hepes buffer at 37  °  C for 
the indicated time periods. Upon incubation the cells where placed on ice 
and the medium was transferred to tubes where the medium was precipi-
tated with 50% TCA and 10% phosphotungstic acid (TCA-PTA) for 1 h at 
4  °  C before the TCA-precipitable and the TCA-soluble radioactivity were sep-
arated into two fractions representing recycled (TCA-precipitable) and de-
graded (TCA-soluble) [ 
125  I]EGF. Both fractions were analyzed in a      counter. 
The cells remaining in the wells were washed with ice-cold PBS before 1% 
SDS in PBS was added and the cells were collected and analyzed in a 
     counter. This fraction represents internalized and cell-associated [ 
125  I]EGF. 
  Statistical analyses 
  Differences between control and treatment groups were tested using a Stu-
dent  ’  s   t   test. 
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